Senior Manager, SAP Technical Services

Princeton, New Jersey, United States

Auto‑apply with AI Apply

$180,000 – $220,000Compensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Information Technology, Software DevelopmentIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Systems, or a related field, along with a minimum of 8 years of experience in SAP technical services, specifically with OpenText Output Management, OpenText IXOS archiving solutions, AutoSys, SAP Solution Manager and SAP Cloud ALM. Strong experience in system integration, system optimization, and alignment with internal processes is essential.

Responsibilities

The Senior Manager, SAP Technical Services will oversee the design and integration of OpenText Output Management, OpenText IXOS archiving solutions, AutoSys, SAP Solution Manager and SAP Cloud ALM, define strategies for system enhancement and future scalability, manage internal projects including scope, planning, execution, and implementation, collaborate with cross-functional teams and vendors, ensure adherence to regulatory requirements and data security policies, conduct regular audits and reviews to maintain high standards, identify opportunities for automation and AI adaptation, ensure system availability and performance, provide guidance to teams on best practices, and lead troubleshooting efforts and root cause analysis for system issues.

Skills

SAP Solution Manager

OpenText Output Management

OpenText IXOS

AutoSys

System Integration

System Optimization

SAP Cloud ALM

Data Security

Troubleshooting

Root Cause Analysis

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free